AIM cash shell Summerway Capital acquired Vertigrow Technology and changed its name to Celadon Pharmaceuticals. The all-share deal valued Vertigrow at £80m. Celadon is the largest cannabis-related business to come to AIM in recent years when these businesses have become more prevalent as investments, particularly on Aquis. Of course, GW Pharmaceuticals joined AIM two decades ago before leaving for Nasdaq.
Celadon is in the process of gaining the additional approvals to manufacture cannabis products – there is already a licence for the growing of cannabis that lasts until January 2023. This...
